News Roche Holding AG Swiss Exchange

Equities

RO

CH0012032113

Market Closed - Swiss Exchange Other stock markets 11:30:51 2024-04-16 am EDT			5-day change	1st Jan Change
237.8 ^CHF	-1.98%		+0.08%	-9.03%

Apr. 15	ROCHE HOLDINGS AG : JP Morgan reiterates its Sell rating	ZD
Apr. 15	Roche: positive phase III data in lymphoma	CF

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ROCHE HOLDINGS AG : JP Morgan reiterates its Sell rating	Apr. 15	ZD
Roche: positive phase III data in lymphoma	Apr. 15	CF
Roche's Late-stage Trial for Columvi Antibody Meets Primary Survival Endpoint in B-cell Lymphoma	Apr. 15	MT
Roche's Columvi Meets Main Goal in Lymphoma Phase 3 Trial	Apr. 15	DJ
Genentech’s Columvi Meets Primary Endpoint of Overall Survival in People With Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Phase III STARGLO Study	Apr. 15	BU
ROCHE HOLDINGS AG : JP Morgan reaffirms its Sell rating	Apr. 12	ZD
Swiss Market Index Falls as ECB Signals June Rate Cut	Apr. 11	MT
ROCHE HOLDINGS AG : Berenberg reiterates its Neutral rating	Apr. 11	ZD
Roche: designation for Alzheimer's test	Apr. 11	CF
Roche, Eli Lilly Alzheimer's Blood Test to Get Expedited FDA Review	Apr. 11	DJ
Roche, Eli Lilly's Elecsys Blood Test Secures US FDA's Breakthrough Device Designation	Apr. 11	MT
Roche Receives FDA Breakthrough Device Designation for Blood Test to Support Early Alzheimer's Disease Diagnosis	Apr. 11	CI
Swiss Market Index Little Changed; Barry Callebaut Shines on Revenue Jump	Apr. 10	MT
Roche’s HER2-Low Metastatic Breast Cancer Diagnostic Test Secures CE Mark	Apr. 10	MT
Roche: CE mark for Enhertu companion test	Apr. 10	CF
Novartis to cut 680 jobs in product development	Apr. 09	RE
ROCHE HOLDINGS AG : UBS reiterates its Neutral rating	Apr. 09	ZD
ROCHE HOLDINGS AG : Barclays gives a Neutral rating	Apr. 08	ZD
Roche: positive phase II data in hypertension	Apr. 08	CF
Roche's Hypertension Drug Meets Primary Endpoint of Reduced Systolic Blood Pressure in Mid-stage Trial	Apr. 08	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ROCHE HOLDING : Q4 miss weighed heavily on the healthy 2024 guidance

February 01, 2024 at 07:42 am EST

Obesity: Roche joins the battle

December 04, 2023 at 10:48 am EST